Structure |
Chemical Name |
CAS |
MF |
![3-methyl-2-pentylphenol](/CAS/20200331/GIF/1823068-39-8.gif) |
3-methyl-2-pentylphenol |
1823068-39-8 |
C12H18O |
![5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[(1E)-2-(4-methyl-5-thiazolyl)ethenyl]-8-oxo-7-[(2-phenylacetyl)amino]-, (4-methoxyphenyl)methyl ester, (6R,7R)-](/CAS/20210305/GIF/104146-11-4.gif) |
5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[(1E)-2-(4-methyl-5-thiazolyl)ethenyl]-8-oxo-7-[(2-phenylacetyl)amino]-, (4-methoxyphenyl)methyl ester, (6R,7R)- |
104146-11-4 |
C29H27N3O5S2 |
![diltiazem hydrochloride](/CAS/GIF/103532-27-0.gif) |
diltiazem hydrochloride |
103532-27-0 |
C22H27ClN2O4S |
![2'-[(1H-Tetrazol-5-yl)biphenyl-4-yl]Methanol](/CAS/GIF/160514-13-6.gif) |
2'-[(1H-Tetrazol-5-yl)biphenyl-4-yl]Methanol |
160514-13-6 |
C14H12N4O |
![(2R,4S)-4-([1,1'-Biphenyl]-4-ylmethyl)-2-methyl-4-(2,5-dioxopyrrolidin-1-yl)butanoic acid](/CAS/20180702/GIF/1639970-62-9.gif) |
(2R,4S)-4-([1,1'-Biphenyl]-4-ylmethyl)-2-methyl-4-(2,5-dioxopyrrolidin-1-yl)butanoic acid |
1639970-62-9 |
C22H23NO4 |
![Ofloxacin/Levofloxacin Impurity A](/) |
Ofloxacin/Levofloxacin Impurity A |
|
|
![(R,R)-Palonosetron N-Oxide](/CAS/20181212/GIF/CB18879407.gif) |
(R,R)-Palonosetron N-Oxide |
|
C19H24N2O2 |
![7-PACE Impurity 2](/) |
7-PACE Impurity 2 |
|
|
![Desloratadine IMpurity 3](/CAS/20180906/GIF/1346600-61-0.gif) |
Desloratadine IMpurity 3 |
1346600-61-0 |
C19H19ClN2 |
![EMpagliflozin iMpurity 11](/) |
EMpagliflozin iMpurity 11 |
|
|
![LCZ Impurity](/CAS/20210111/GIF/753421-85-1.gif) |
LCZ Impurity |
753421-85-1 |
C20H25NO2 |
![(3S,5R)-4-[5-([1,1'-Biphenyl]-4-ylmethyl)-3-methyl-2-oxopyrrolidin-1-yl]-4-oxobutanoic acid](/CAS/20180702/GIF/CB22995779.gif) |
(3S,5R)-4-[5-([1,1'-Biphenyl]-4-ylmethyl)-3-methyl-2-oxopyrrolidin-1-yl]-4-oxobutanoic acid |
|
C22H23NO4 |
![Ethyl (2R,4S)-4-([1,1'-biphenyl]-4-ylmethyl)-4-[4-(propan-2-yloxy)-4-oxobutanamido]-2-methylbutanoate](/CAS/20180702/GIF/CB22995784.gif) |
Ethyl (2R,4S)-4-([1,1'-biphenyl]-4-ylmethyl)-4-[4-(propan-2-yloxy)-4-oxobutanamido]-2-methylbutanoate |
|
C27H35NO5 |
![Formoterol EP Impurity E](/CAS/20180808/GIF/1616967-26-0.gif) |
Formoterol EP Impurity E |
1616967-26-0 |
C20H26N2O4 |
![(Glu3)-Carbetocin (Impurity D)](/) |
(Glu3)-Carbetocin (Impurity D) |
|
|
![Δ3-7-ACT](/) |
Δ3-7-ACT |
|
|
![(2R,4S)-5-([1,1'-biphenyl]-4-yl)-4-aMino-2-Methylpentanoic acid hydrochloride](/CAS/20150408/GIF/1038924-71-8.gif) |
(2R,4S)-5-([1,1'-biphenyl]-4-yl)-4-aMino-2-Methylpentanoic acid hydrochloride |
1038924-71-8 |
C18H22ClNO2 |
![(2S,4S)-5-(Biphenyl-4-yl)-4-[(3-carboxypropionyl)amino]-2-methylpentanoic acid ethyl ester,calcium salt(2:1)](/) |
(2S,4S)-5-(Biphenyl-4-yl)-4-[(3-carboxypropionyl)amino]-2-methylpentanoic acid ethyl ester,calcium salt(2:1) |
|
|
![1-Azetidinesulfonamide(9CI)](/CAS/GIF/654073-32-2.gif) |
1-Azetidinesulfonamide(9CI) |
654073-32-2 |
C3H8N2O2S |
![N-DESMETHYLGALANTHAMINE](/CAS/GIF/41303-74-6.gif) |
N-DESMETHYLGALANTHAMINE |
41303-74-6 |
C16H19NO3 |
![Hydroxy Adapalene](/CAS/GIF/1346599-76-5.gif) |
Hydroxy Adapalene |
1346599-76-5 |
C28H28O4 |
![Adefovir iMpurity](/CAS/20211123/GIF/1875153-79-9.gif) |
Adefovir iMpurity |
1875153-79-9 |
C15H24N5O6P |
![tert-butyl 4-cyclohexylpiperazine-1-carboxylate](/CAS/20150408/GIF/1224935-95-8.gif) |
tert-butyl 4-cyclohexylpiperazine-1-carboxylate |
1224935-95-8 |
C15H28N2O2 |
![Avanafil iMpurity 1](/CAS/20210111/GIF/372117-54-9.gif) |
Avanafil iMpurity 1 |
372117-54-9 |
C18H22ClN5O3 |
![Avanafil Impurity 9](/) |
Avanafil Impurity 9 |
|
|
![ethyl(2R,4S)-5-([1,1'-biphenyl]-4-yl)-4-(4-ethoxy-4-oxobutanamido)-2-methylpentanoate](/CAS/20200119/GIF/CB33130105.gif) |
ethyl(2R,4S)-5-([1,1'-biphenyl]-4-yl)-4-(4-ethoxy-4-oxobutanamido)-2-methylpentanoate |
|
C26H33NO5 |
![phenyl (4-((6-carbamoyl-7-methoxyquinolin-4-yl)oxy)-2-chlorophenyl)carbamate](/CAS/20180702/GIF/417722-95-3.gif) |
phenyl (4-((6-carbamoyl-7-methoxyquinolin-4-yl)oxy)-2-chlorophenyl)carbamate |
417722-95-3 |
C24H18ClN3O5 |
![Lacosamide Impurity – K](/) |
Lacosamide Impurity – K |
|
|
![(1R,3aS,4E,7aR)-4-[(2E)-2-[(3S,5R)-3,5-bis[[(1,1-dimethylethyl)dimethylsilyl]oxy]-2-methylenecyclohexylidene]ethylidene]octahydro-7a-methyl-1-[(1R,4S)-1,4,5-trimethylhexyl]-1H-Indene](/CAS/20210111/GIF/2229745-37-1.gif) |
(1R,3aS,4E,7aR)-4-[(2E)-2-[(3S,5R)-3,5-bis[[(1,1-dimethylethyl)dimethylsilyl]oxy]-2-methylenecyclohexylidene]ethylidene]octahydro-7a-methyl-1-[(1R,4S)-1,4,5-trimethylhexyl]-1H-Indene |
2229745-37-1 |
C40H74O2Si2 |
![Ofloxacin/Levofloxacin Impurity B](/) |
Ofloxacin/Levofloxacin Impurity B |
|
|
![(2R,4S)-isopropyl5-([1,1'-biphenyl]-4-yl)-4-(2,5-dioxopyrrolidin-1- yl)-2-methylpentanoate](/CAS/20200331/GIF/CB45441220.gif) |
(2R,4S)-isopropyl5-([1,1'-biphenyl]-4-yl)-4-(2,5-dioxopyrrolidin-1- yl)-2-methylpentanoate |
|
C25H29NO4 |
![Amylmetacresol EP impurity A](/CAS/20210111/GIF/876473-73-3.gif) |
Amylmetacresol EP impurity A |
876473-73-3 |
C12H18O |
![5-methyl-2-(2-methylbutyl)phenol](/CAS/20200331/GIF/CB45559703.gif) |
5-methyl-2-(2-methylbutyl)phenol |
|
C12H18O |
![7-ADCA Impuirty 1](/) |
7-ADCA Impuirty 1 |
|
|
![7-PACE Impurity 1](/) |
7-PACE Impurity 1 |
|
|
![(R)-Fluvastatin EP Impurity E](/) |
(R)-Fluvastatin EP Impurity E |
|
|
![5-(2-cyclopropyl-2-oxo-1-phenylethyl)-4,5,6,7-tetrahydrothieno [3,2-c]pyridin-2-yl acetate](/CAS/20150408/GIF/1391194-45-8.gif) |
5-(2-cyclopropyl-2-oxo-1-phenylethyl)-4,5,6,7-tetrahydrothieno [3,2-c]pyridin-2-yl acetate |
1391194-45-8 |
C20H21NO3S |
![(Gly8-OH)-Carbetocin (Impurity B)](/) |
(Gly8-OH)-Carbetocin (Impurity B) |
|
|
![D-Asn4-Carbetocin (Impurity F)](/) |
D-Asn4-Carbetocin (Impurity F) |
|
|
![5-Chloro AcesulfaMe](/CAS/20180808/GIF/72827-08-8.gif) |
5-Chloro AcesulfaMe |
72827-08-8 |
C4H4ClNO4S |
![Ethyl (2R,4S)-4-([1,1'-biphenyl]-4-ylmethyl)-2-methyl-4-(2,5-dioxopyrrolidin-1-yl)butanoate](/CAS/20180703/GIF/1038924-97-8.gif) |
Ethyl (2R,4S)-4-([1,1'-biphenyl]-4-ylmethyl)-2-methyl-4-(2,5-dioxopyrrolidin-1-yl)butanoate |
1038924-97-8 |
C24H27NO4 |
![3'-chloro-3'-deoxythymidine (zidovudine impurity)](/) |
3'-chloro-3'-deoxythymidine (zidovudine impurity) |
|
|
![Ofloxacin/Levofloxacin Impurity E](/) |
Ofloxacin/Levofloxacin Impurity E |
|
|
![4-(4-Hydroxy-3-hydroxymethyl-phenoxy)-benzonitrile](/CAS/20200401/GIF/CB74870042.gif) |
4-(4-Hydroxy-3-hydroxymethyl-phenoxy)-benzonitrile |
|
C14H11NO3 |
![monocalciummono(4-(((2S,4R)-1-([1,1'-biphenyl]-4-yl)-5- methoxy-4-methyl-5-oxopentan-2-yl)amino)-4-oxobutanoate)](/CAS/20200401/GIF/CB75441221.gif) |
monocalciummono(4-(((2S,4R)-1-([1,1'-biphenyl]-4-yl)-5- methoxy-4-methyl-5-oxopentan-2-yl)amino)-4-oxobutanoate) |
|
C23H26CaNO5 |
![(2R,4S)-Isopropyl 5-([1,1''-biphenyl]-4-yl)-4-(4-isopropoxy-4-oxobutanamido)-2-methylpentanoate](/CAS/20210111/GIF/2216755-67-6.gif) |
(2R,4S)-Isopropyl 5-([1,1''-biphenyl]-4-yl)-4-(4-isopropoxy-4-oxobutanamido)-2-methylpentanoate |
2216755-67-6 |
C28H37NO5 |
![EP Impurity Catalog](/) |
EP Impurity Catalog |
|
|
![2,4,6,3',5'-pentamethoxybiphenyl](/CAS/20210305/GIF/84212-55-5.gif) |
2,4,6,3',5'-pentamethoxybiphenyl |
84212-55-5 |
C17H20O5 |
![(Asp4)-Carbetocin (Impurity G)](/) |
(Asp4)-Carbetocin (Impurity G) |
|
|
![((1R,3R,E)-5-((E)-2-((1R,3aS,7aR)-1-((2R,5R,E)-5,6-diMethylhept-3-en-2-yl)-7a-Methyldihydro-1H-inden-4(2H,5H,6H,7H,7aH)-ylidene)ethylidene)-4-Methylenecyclohexane-1,3-diyl)bis(oxy)bis(tert-butyldiMethylsilane)](/CAS/GIF/115540-28-8.gif) |
((1R,3R,E)-5-((E)-2-((1R,3aS,7aR)-1-((2R,5R,E)-5,6-diMethylhept-3-en-2-yl)-7a-Methyldihydro-1H-inden-4(2H,5H,6H,7H,7aH)-ylidene)ethylidene)-4-Methylenecyclohexane-1,3-diyl)bis(oxy)bis(tert-butyldiMethylsilane) |
115540-28-8 |
C40H72O2Si2 |
![(S,R)-Palonosetron N-Oxide](/CAS/20181212/GIF/CB88879406.gif) |
(S,R)-Palonosetron N-Oxide |
|
C19H24N2O2 |
![2-Hydroxymethyl Olanzapine](/CAS/GIF/174756-45-7.gif) |
2-Hydroxymethyl Olanzapine |
174756-45-7 |
C17H20N4OS |
![Flomoxef Impurity 2](/) |
Flomoxef Impurity 2 |
|
|
![4-Isobutylacetophenone (Ibuprofen impurity)](/) |
4-Isobutylacetophenone (Ibuprofen impurity) |
|
|
![Afatinib Impurity 17](/CAS/20210111/GIF/1870880-09-3.gif) |
Afatinib Impurity 17 |
1870880-09-3 |
C20H18Cl2FN5O |
![Abiraterone Impurity 4](/CAS/20211123/GIF/2118-32-3.gif) |
Abiraterone Impurity 4 |
2118-32-3 |
C23H34O2 |
![4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)thiazol-2-amine](/CAS/20200119/GIF/570407-42-0.gif) |
4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)thiazol-2-amine |
570407-42-0 |
C17H23ClN4S2 |
![T-IRR](/) |
T-IRR |
|
|
![Avatrombopag Impurity 23](/) |
Avatrombopag Impurity 23 |
|
|
![Avatrombopag Impurity 34](/) |
Avatrombopag Impurity 34 |
|
|
![3-Chloro Avanafil](/) |
3-Chloro Avanafil |
|
|
![Avanafil IMpurity 8 (R-Avanafil)](/) |
Avanafil IMpurity 8 (R-Avanafil) |
|
|
![570403-04-2](/CAS/20200515/GIF/570403-04-2.gif) |
570403-04-2 |
570403-04-2 |
C23H24Cl3N5OS2 |
![5-chloro-6-[4-(ethoxycarbonyl)piperidino]nicotinic acid](/CAS/GIF/931395-73-2.gif) |
5-chloro-6-[4-(ethoxycarbonyl)piperidino]nicotinic acid |
931395-73-2 |
C14H17ClN2O4 |
![Afatinib Impurity 14](/) |
Afatinib Impurity 14 |
|
|
![Avanafil Impurity 10](/) |
Avanafil Impurity 10 |
|
|
![Adefovir Impurity 2](/) |
Adefovir Impurity 2 |
|
|
![Abacavir Impurity F](/CAS/20200515/GIF/1443421-68-8.gif) |
Abacavir Impurity F |
1443421-68-8 |
C18H26N6O |
![Albendazole EP Impurity J](/CAS/20210305/GIF/946498-41-5.gif) |
Albendazole EP Impurity J |
946498-41-5 |
C9H7Cl2N3O2 |
![Afatinib impurity 33](/) |
Afatinib impurity 33 |
|
|
![Abitrone project impurity](/) |
Abitrone project impurity |
|
|
![1364671-52-2](/CAS/20210111/GIF/1364671-52-2.gif) |
1364671-52-2 |
1364671-52-2 |
C19H19ClN6O3S |
![Sugammadex disulfide Impurity](/) |
Sugammadex disulfide Impurity |
|
|
![2-Thiazolamine, 5-bromo-4-(5-bromo-4-chloro-2-thienyl)-](/CAS/20200611/GIF/2401867-89-6.gif) |
2-Thiazolamine, 5-bromo-4-(5-bromo-4-chloro-2-thienyl)- |
2401867-89-6 |
C7H3Br2ClN2S2 |
![Avatrombopag Impurity 31](/) |
Avatrombopag Impurity 31 |
|
|
![Avatrombopag Impurity 75](/) |
Avatrombopag Impurity 75 |
|
|
![N4,N7-bis(3-chloro-4-fluorophenyl)-8-nitroquinazoline-4,7-diamine](/) |
N4,N7-bis(3-chloro-4-fluorophenyl)-8-nitroquinazoline-4,7-diamine |
|
|
![Abiraterone Sulfate](/CAS/20181212/GIF/CB22673383.gif) |
Abiraterone Sulfate |
|
|
![Avanafil iMpurity 5](/) |
Avanafil iMpurity 5 |
|
|
![Adefovir Dipivoxil Impurity E](/CAS/20210111/GIF/116384-54-4.gif) |
Adefovir Dipivoxil Impurity E |
116384-54-4 |
C10H16N5O4P |
![Afatinib Impurity 22](/) |
Afatinib Impurity 22 |
|
|
![Adefovir Impurity 6](/) |
Adefovir Impurity 6 |
|
|
![Afatinib impurity 30](/) |
Afatinib impurity 30 |
|
|
![N - hydroxy Tropisetron Impurity 2](/) |
N - hydroxy Tropisetron Impurity 2 |
|
|
![2-bromo-1-(4-chlorothiophen-2-yl)ethanone](/CAS/20200611/GIF/677007-73-7.gif) |
2-bromo-1-(4-chlorothiophen-2-yl)ethanone |
677007-73-7 |
C6H4BrClOS |
![3-Pyridinecarboxamide, 5-chloro-N-[4-(4-chloro-2-thienyl)-5-(4-cyclohexyl-1-piperazinyl)-2-thiazolyl]-1,6-dihydro-6-oxo-](/CAS/20210305/GIF/762237-66-1.gif) |
3-Pyridinecarboxamide, 5-chloro-N-[4-(4-chloro-2-thienyl)-5-(4-cyclohexyl-1-piperazinyl)-2-thiazolyl]-1,6-dihydro-6-oxo- |
762237-66-1 |
C23H25Cl2N5O2S2 |
![Avatrombopag Impurity 39](/) |
Avatrombopag Impurity 39 |
|
|
![Avatrombopag Impurity 54](/) |
Avatrombopag Impurity 54 |
|
|
![N-(7-chloro-4-((3-chloro-4-fluorophenyl)amino)quinazolin-6-yl)-4-(dimethylamino)butanamide](/) |
N-(7-chloro-4-((3-chloro-4-fluorophenyl)amino)quinazolin-6-yl)-4-(dimethylamino)butanamide |
|
|
![Pyridine, 2-(diethylboryl)- (9CI)](/CAS/GIF/385804-67-1.gif) |
Pyridine, 2-(diethylboryl)- (9CI) |
385804-67-1 |
C9H14BN |
![Avanafil iMpurity 2](/) |
Avanafil iMpurity 2 |
|
|
![Afatinib Impurity 18](/CAS/20200611/GIF/2316847-95-5.gif) |
Afatinib Impurity 18 |
2316847-95-5 |
C22H20ClFN4O4 |
![5-bromo-4-(4-chlorothiophen-2-yl)thiazol-2-amine](/CAS/20200119/GIF/2161380-87-4.gif) |
5-bromo-4-(4-chlorothiophen-2-yl)thiazol-2-amine |
2161380-87-4 |
C7H4BrClN2S2 |
![Afatinib Impurity 24](/) |
Afatinib Impurity 24 |
|
|
![Afatinib impurity 27](/) |
Afatinib impurity 27 |
|
|
![Adefovir Impurity 4](/) |
Adefovir Impurity 4 |
|
|
![Aclidinium Bromide Impurity 1](/) |
Aclidinium Bromide Impurity 1 |
|
|
![Sugammadex Monohydroxy Impurity](/) |
Sugammadex Monohydroxy Impurity |
|
|
![Avatrombopag Impurity 35](/) |
Avatrombopag Impurity 35 |
|
|
![3-Pyridinecarboxamide, 5-chloro-N-[4-(4-chloro-2-thienyl)-5-(4-cyclohexyl-1-piperazinyl)-2-thiazolyl]-6-(dimethylamino)-](/CAS/20210305/GIF/2626934-45-8.gif) |
3-Pyridinecarboxamide, 5-chloro-N-[4-(4-chloro-2-thienyl)-5-(4-cyclohexyl-1-piperazinyl)-2-thiazolyl]-6-(dimethylamino)- |
2626934-45-8 |
C25H30Cl2N6OS2 |